425 ·Filed Sep 14, 2026

MMED

MiniMed Group, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed18d 3h ago SEC0001628280-26-061714
Rule 425 M&A communications
Actionable Insight • Neutral

This filing is procedural and contains no new financial data or deal terms. Monitor the S-4 prospectus and Schedule TO for exchange offer details, including the exchange ratio and timeline. The key catalyst is the completion of the exchange offer, which will make MiniMed a fully independent company.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+5d ⚠ clustered
MMED ▼ -3.87% at T+5d
NEUTRAL call ✗ call lost -3.87% · α vs SPY -3.98% · entry $21.97 → $21.12
Next anchor: T+20d in 10d
Latest observation: T+9 -12.44% FF3 residual α
Entry anchored
Sep 14, 08:55 AM ET
via 1-min bar
T+1d
+0.18%
call +0.18% · α +0.64%
$22.01
settled 17d ago
T+5d
-3.87%
call -3.87% · α -3.98%
$21.12
settled 11d ago
T+20d
—
call — · α —
—
in 10d
T+60d
—
call — · α —
—
in 2mo

Price Chart

Loading chart...

Executive Summary

Medtronic has launched an exchange offer to split off its remaining equity interest in MiniMed, as confirmed by this internal employee communication. The filing is a procedural step toward MiniMed's full independence, with no new financial terms, deal changes, or market-moving information disclosed. The CEO's earlier message noted operational milestones including crossing $3 billion in annual revenue and product launches, but this specific document is a reactive messaging guide for customer-facing teams.

Key Financial Metrics

Deal Type
other

Key Facts

  • Medtronic launched an exchange offer to split off its remaining equity interest in MiniMed.
  • MiniMed filed a Form S-4 registration statement with the SEC as a required step toward becoming an independent company.
  • The filing is a reactive messaging guide for customer-facing teams, not a disclosure of new financial or deal terms.
  • CEO Que Dallara previously noted MiniMed crossed $3 billion in annual revenue and launched MiniMed Flex and MiniMed Go products.
  • Medtronic has retained D.F. King & Co. as the information agent for the exchange offer.

Financial Impact

No new financial figures disclosed in this filing. Prior CEO communication referenced crossing $3 billion in annual revenue.

Risk Factors

  • Exchange offer may not be completed if conditions are not satisfied.
  • Transition service agreements with Medtronic may face execution risks during the 18-24 month wind-down.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
89% bullish (18 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
425 Filing (Primary)0001628280-26-061714
Document: 0001628280-26-061714-index-headers.html0001628280-26-061714
Document: 0001628280-26-061714-index.html0001628280-26-061714
Document: 0001628280-26-061714.txt0001628280-26-061714
17 reports for MMED
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for MMED — sortable, filterable
TypeNow
Sep 14, 2026
18d ago
425
NEUTRAL ★ 4/10
$21.97 $21.12▼ −3.87%▼ −3.98%$19.56 (−10.97%)
Sep 14, 2026
18d ago
425
NEUTRAL ★ 4/10
$21.97 $21.12▼ −3.87%▼ −3.98%$19.56 (−10.97%)
Sep 14, 2026
18d ago
425
MIXED ★ 5/10
$21.97 $21.12▼ −3.87%▼ −3.98%$19.56 (−10.97%)
Sep 14, 2026
18d ago
425
NEUTRAL ★ 4/10
$21.97 $21.12▼ −3.87%▼ −3.98%$19.56 (−10.97%)
Sep 14, 2026
18d ago
425
NEUTRAL ★ 4/10
$21.97 $21.12▼ −3.87%▼ −3.98%$19.56 (−10.97%)
Sep 14, 2026
18d ago
425
BULLISH ★ 6/10
$21.97 $21.12▼ −3.87%▼ −3.98%$19.56 (−10.97%)
Sep 14, 2026
18d ago
S-4 / 425
NEUTRAL ★ 6/10
$21.97 $21.12▼ −3.87%▼ −3.98%$19.56 (−10.97%)
Sep 1, 2026
4w ago
8-K
BULLISH ★ 7/10
$22.42 $22.76▲ +1.52%▲ +1.44%$19.56 (−12.76%)
Jul 6, 2026
12w ago
3
NEUTRAL ★ 1/10
$15.37 $15.04▼ −2.15%▼ −2.70%$19.56 (+27.26%)
Jun 29, 2026
13w ago
8-K
NEUTRAL ★ 2/10
$14.88 $15.29▲ +2.76%▲ +1.37%$19.56 (+31.45%)
Showing 10 of 17

US Market Status

Market Open — Closes in 2h 20m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access